Citadel Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Buy
317,934
+63,214
+25% +$2.82M ﹤0.01% 3055
2025
Q4
$11.9M Sell
254,720
-629,787
-71% -$28M ﹤0.01% 3036
2025
Q3
$36.8M Buy
884,507
+230,872
+35% +$7.38M 0.01% 1679
2025
Q2
$18.8M Buy
653,635
+615,084
+1,596% +$19M ﹤0.01% 2221
2025
Q1
$1.29M Buy
38,551
+33,829
+716% +$1.26M ﹤0.01% 6380
2024
Q4
$241K Sell
4,722
-130,412
-97% -$7.3M ﹤0.01% 10100
2024
Q3
$6.91M Buy
135,134
+13,255
+11% +$684K ﹤0.01% 3441
2024
Q2
$5.46M Sell
121,879
-49,545
-29% -$2.29M ﹤0.01% 3609
2024
Q1
$8.02M Buy
171,424
+148,632
+652% +$5.82M ﹤0.01% 3235
2023
Q4
$811K Sell
22,792
-136,444
-86% -$4.18M ﹤0.01% 7109
2023
Q3
$4.74M Sell
159,236
-82,492
-34% -$1.7M ﹤0.01% 3735
2023
Q2
$4.36M Sell
241,728
-43,867
-15% -$875K ﹤0.01% 3854
2023
Q1
$4.59M Buy
285,595
+248,239
+665% +$4.59M ﹤0.01% 3960
2022
Q4
$684K Sell
37,356
-2,855
-7% -$50.3K ﹤0.01% 7589
2022
Q3
$790K Buy
+40,211
New +$820K ﹤0.01% 7493
2022
Q2
Sell
-49,839
Closed -$995K 13013
2022
Q1
$1.09M Sell
49,839
-14,985
-23% -$303K ﹤0.01% 7493
2021
Q4
$1.84M Buy
64,824
+27,605
+74% +$681K ﹤0.01% 6437
2021
Q3
$783K Sell
37,219
-23,439
-39% -$490K ﹤0.01% 8761
2021
Q2
$1.14M Buy
+60,658
New +$1.07M ﹤0.01% 8007
2021
Q1
Sell
-46,864
Closed -$661K 13218
2020
Q4
$661K Buy
46,864
+7,762
+20% +$108K ﹤0.01% 7611
2020
Q3
$613K Buy
39,102
+6,076
+18% +$92.9K ﹤0.01% 6924
2020
Q2
$579K Sell
33,026
-2,711
-8% -$46.2K ﹤0.01% 6809
2020
Q1
$526K Buy
35,737
+7,809
+28% +$160K ﹤0.01% 6383
2019
Q4
$701K Buy
27,928
+295
+1% +$5.62K ﹤0.01% 6234
2019
Q3
$416K Buy
27,633
+15,839
+134% +$308K ﹤0.01% 7067
2019
Q2
$295K Buy
+11,794
New +$292K ﹤0.01% 7609

Other funds holding CRNX